Log in to save to my catalogue

O32 Skin proteome investigation in cutaneous lupus erythematosus (CLE) reveals novel unique disease...

O32 Skin proteome investigation in cutaneous lupus erythematosus (CLE) reveals novel unique disease...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_bmj_primary_10_1136_lupus_2020_eurolupus_43

O32 Skin proteome investigation in cutaneous lupus erythematosus (CLE) reveals novel unique disease pathways

About this item

Full title

O32 Skin proteome investigation in cutaneous lupus erythematosus (CLE) reveals novel unique disease pathways

Journal title

Lupus science & medicine, 2020, Vol.7 (Suppl 1), p.A25

Language

English

More information

Scope and Contents

Contents

BackgroundCutaneous Lupus Erythematosus (CLE) is an autoimmune disease. It can be limited to the skin or be one of manifestations of systemic LE (SLE). The typical histopathologic pattern in CLE/SLE is interface dermatitis, which can also be observed in dermatomyositis (DM). While LE may affect any organ system, DM most commonly affect muscles and...

Alternative Titles

Full title

O32 Skin proteome investigation in cutaneous lupus erythematosus (CLE) reveals novel unique disease pathways

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_bmj_primary_10_1136_lupus_2020_eurolupus_43

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_bmj_primary_10_1136_lupus_2020_eurolupus_43

Other Identifiers

E-ISSN

2053-8790

DOI

10.1136/lupus-2020-eurolupus.43

How to access this item